Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
zejula 100 mg kapseln
glaxosmithkline ag - niraparibum - kapseln - kapsel: niraparibum 100 mg zu niraparibi tosilas monohydricus, color.: e 133, e 127, e 102, excipiens für die kapsel. - onkologikum - synthetika
Europäische Union -
Deutsch -
EMA (European Medicines Agency)
zejula
glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - antineoplastische mittel - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.
Europäische Union -
Deutsch -
EMA (European Medicines Agency)
akeega
janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatahyperplasie neubildungen, kastration-resistentem - antineoplastische mittel - treatment of adult patients with prostate cancer.
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
zejula 100 mg filmtabletten
glaxosmithkline ag - niraparibum - filmtabletten - niraparibum 100 mg ut niraparibi tosilas monohydricus, cellulosum microcristallinum, lactosum monohydricum 34.66 mg, povidonum k 30, crospovidonum, silica colloidalis hydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (nigrum), pro compresso obducto. - onkologikum - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
rubraca 200 mg filmtabletten
mmpharm gmbh - rucaparibum - filmtabletten - rucaparibum 200 mg ut rucaparibi camsilas, cellulosum microcristallinum, carboxymethylamylum natricum a, silica colloidalis anhydrica, magnesii stearas, poly(alcohol vinylicus), macrogolum 4000, talcum, e 171, e 132, e 133, pro compresso obducto corresp. natrium max. 1.2 mg. - ovarial-, eileiter- oder primäres peritonealkarzinom - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
rubraca 250 mg filmtabletten
mmpharm gmbh - rucaparibum - filmtabletten - rucaparibum 250 mg ut rucaparibi camsilas, cellulosum microcristallinum, carboxymethylamylum natricum a, silica colloidalis anhydrica, magnesii stearas, poly(alcohol vinylicus), macrogolum 4000, talcum, e 171, pro compresso obducto corresp. natrium max. 1.5 mg. - ovarial-, eileiter- oder primäres peritonealkarzinom - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
rubraca 300 mg filmtabletten
mmpharm gmbh - rucaparibum - filmtabletten - rucaparibum 300 mg ut rucaparibi camsilas, cellulosum microcristallinum, carboxymethylamylum natricum a, silica colloidalis anhydrica, magnesii stearas, poly(alcohol vinylicus), macrogolum 4000, talcum, e 171, e 172 (flavum), pro compresso obducto corresp. natrium max. 1.8 mg. - ovarial-, eileiter- oder primäres peritonealkarzinom - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
lynparza 100 mg filmtabletten
astrazeneca ag - olaparibum - filmtabletten - olaparibum 100 mg, excipiens pro compresso obducto. - onkologikum - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
lynparza 150 mg filmtabletten
astrazeneca ag - olaparibum - filmtabletten - olaparibum 150 mg, excipiens pro compresso obducto. - onkologikum - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
lynparza 50 mg kapseln
astrazeneca ag - olaparibum - kapseln - olaparibum 50 mg, macrogolglyceridorum laurates, kapselhülle: hypromellosum, e 171, gellani gummi, kalii acetas, drucktinte: lacca, e 172 (nigrum), pro capsula. - onkologikum - synthetika